Form D — Beacon Biosignals, Inc.
0001765647-26-000001 · filed 2026-04-15
Offering
- Industry
- Other Technology
- Exemptions
- 06b
- Total offering
- $103,280,711
- Total sold
- $103,280,711
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Beacon Biosignals, Inc.
- CIK
- 1765647
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 22 Boston Wharf Road
BOSTON, MA 02210 - Phone
- 401-225-5782
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jacob A. Donoghue, M.D., Ph.D. · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Jarrett Revels · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Caitlin Donovan · DirectorBoston, MA Find on LinkedIn ↗
-
Pavel Raifeld · DirectorBoston, MA Find on LinkedIn ↗
-
Naveen Rao · DirectorBoston, MA Find on LinkedIn ↗
View original on SEC EDGAR.